Portfolio company
Oncascan
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Oncascan developed a non-invasive blood test to detect cancer sensitivity in lymphocytes for clinical laboratories to improve patient management and diagnostic accuracy.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
OXCan
This company develops blood tests using proteomics and machine learning to enable early cancer detection for healthcare providers and patients.
CanSense
This company develops blood-based diagnostic tests using laser spectroscopy and artificial intelligence for early-stage bowel cancer detection for healthcare providers and laboratories.
Infiniplex
This company develops liquid biopsy solutions using blood tests to monitor genetic biomarkers for cancer screening and precision oncology decisions for healthcare providers.
Voc Diagnostics
This company develops diagnostic instruments using machine learning and sensor technology to detect ovarian cancer from blood plasma samples for healthcare providers.
DeepScan Diagnostics
This company develops cell-free DNA blood tests for veterinarians to detect cancer and monitor treatment response in dogs.
Oncobit
This company develops precision diagnostic assays and cloud-based monitoring software for clinicians to track cancer markers and therapy response in oncology patients.
Epiliquid
This company develops blood-based liquid biopsy tests for early cancer detection and monitoring, serving clinical laboratories and medical practitioners.
Oncomark
This company develops prognostic tests for breast cancer patients to help clinicians determine the necessity of chemotherapy treatment.
